| MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease L Kordelas, V Rebmann, AK Ludwig, S Radtke, J Ruesing, TR Doeppner, ... Leukemia 28 (4), 970-973, 2014 | 1043 | 2014 |
| Extracellular vesicles improve post-stroke neuroregeneration and prevent postischemic immunosuppression TR Doeppner, J Herz, A Görgens, J Schlechter, AK Ludwig, S Radtke, ... Stem cells translational medicine 4 (10), 1131-1143, 2015 | 709 | 2015 |
| Mesenchymal stromal cell-derived extracellular vesicles protect the fetal brain after hypoxia-ischemia DRMG Ophelders, TGAM Wolfs, RK Jellema, A Zwanenburg, ... Stem cells translational medicine 5 (6), 754-763, 2016 | 275 | 2016 |
| Mesenchymal stem cell-derived extracellular vesicles ameliorate inflammation-induced preterm brain injury K Drommelschmidt, M Serdar, I Bendix, J Herz, F Bertling, S Prager, ... Brain, behavior, and immunity 60, 220-232, 2017 | 261 | 2017 |
| Revision of the human hematopoietic tree: granulocyte subtypes derive from distinct hematopoietic lineages A Görgens, S Radtke, M Möllmann, M Cross, J Dürig, PA Horn, B Giebel Cell reports 3 (5), 1539-1552, 2013 | 226 | 2013 |
| Hit-and-run programming of therapeutic cytoreagents using mRNA nanocarriers HF Moffett, ME Coon, S Radtke, SB Stephan, L McKnight, A Lambert, ... Nature communications 8 (1), 389, 2017 | 164 | 2017 |
| Mesenchymal stem cells augment the anti-bacterial activity of neutrophil granulocytes S Brandau, M Jakob, K Bruderek, F Bootz, B Giebel, S Radtke, K Mauel, ... PloS one 9 (9), e106903, 2014 | 130 | 2014 |
| Therapeutically relevant engraftment of a CRISPR-Cas9–edited HSC-enriched population with HbF reactivation in nonhuman primates O Humbert, S Radtke, C Samuelson, RR Carrillo, AM Perez, SS Reddy, ... Science translational medicine 11 (503), eaaw3768, 2019 | 105 | 2019 |
| A distinct hematopoietic stem cell population for rapid multilineage engraftment in nonhuman primates S Radtke, JE Adair, MA Giese, YY Chan, ZK Norgaard, M Enstrom, ... Science translational medicine 9 (414), eaan1145, 2017 | 103 | 2017 |
| Human hematopoietic stem cell maintenance and myeloid cell development in next-generation humanized mouse models TR Sippel, S Radtke, TM Olsen, HP Kiem, A Rongvaux Blood advances 3 (3), 268-274, 2019 | 57 | 2019 |
| New relationships of human hematopoietic lineages facilitate detection of multipotent hematopoietic stem and progenitor cells A Görgens, S Radtke, P Horn, B Giebel Cell Cycle 12 (22), 3478-3482, 2013 | 48 | 2013 |
| A nonhuman primate transplantation model to evaluate hematopoietic stem cell gene editing strategies for β-hemoglobinopathies O Humbert, CW Peterson, ZK Norgaard, S Radtke, HP Kiem Molecular Therapy Methods & Clinical Development 8, 75-86, 2018 | 44 | 2018 |
| CD 133 allows elaborated discrimination and quantification of haematopoietic progenitor subsets in human haematopoietic stem cell transplants S Radtke, A Görgens, L Kordelas, M Schmidt, KR Kimmig, A Köninger, ... British journal of haematology 169 (6), 868-878, 2015 | 39 | 2015 |
| Suppression of luteinizing hormone enhances HSC recovery after hematopoietic injury E Velardi, JJ Tsai, S Radtke, K Cooper, KV Argyropoulos, S Jae-Hung, ... Nature medicine 24 (2), 239-246, 2018 | 35 | 2018 |
| Purification of human CD34+ CD90+ HSCs reduces target cell population and improves lentiviral transduction for gene therapy S Radtke, D Pande, M Cui, AM Perez, YY Chan, M Enstrom, S Schmuck, ... Molecular Therapy-Methods & Clinical Development 18, 679-691, 2020 | 34 | 2020 |
| Human mesenchymal and murine stromal cells support human lympho-myeloid progenitor expansion but not maintenance of multipotent haematopoietic stem and progenitor cells S Radtke, A Görgens, B Liu, PA Horn, B Giebel Cell Cycle 15 (4), 540-545, 2016 | 29 | 2016 |
| Multiplex CRISPR/Cas9 genome editing in hematopoietic stem cells for fetal hemoglobin reinduction generates chromosomal translocations C Samuelson, S Radtke, H Zhu, M Llewellyn, E Fields, S Cook, ... Molecular Therapy-Methods & Clinical Development 23, 507-523, 2021 | 27 | 2021 |
| Autologous bone marrow mononuclear cell therapy improves symptoms in patients with end-stage peripheral arterial disease and reduces inflammation-associated parameters NM Malyar, S Radtke, K Malyar, J Arjumand, PA Horn, K Kröger, ... Cytotherapy 16 (9), 1270-1279, 2014 | 26 | 2014 |
| Safe and efficient in vivo hematopoietic stem cell transduction in nonhuman primates using HDAd5/35++ vectors C Li, H Wang, S Gil, A Germond, C Fountain, A Baldessari, J Kim, Z Liu, ... Molecular Therapy-Methods & Clinical Development 24, 127-141, 2022 | 23 | 2022 |
| Efficient polymer nanoparticle-mediated delivery of gene editing reagents into human hematopoietic stem and progenitor cells R El-Kharrag, KE Berckmueller, R Madhu, M Cui, G Campoy, HM Mack, ... Molecular Therapy 30 (6), 2186-2198, 2022 | 22 | 2022 |
Bernd GiebelUniversity of Duisburg-Essen, University Hospital Essen, Institute for Transfusion MedicineVerified email at uk-essen.de
